Paris - Delayed Quote EUR
Virbac SA (VIRP.PA)
304.75
-3.15
(-1.02%)
At close: 5:35:10 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
204,221
204,221
118,641
98,984
129,904
Investing Cash Flow
-428,689
-428,689
-121,869
-54,832
-51,214
Financing Cash Flow
138,585
138,585
-2,723
-34,755
-91,693
End Cash Position
146,037
146,037
173,358
176,679
172,136
Capital Expenditure
-80,439
-80,439
-59,901
-53,577
-47,167
Issuance of Debt
273,632
273,632
88,651
85,439
65,643
Repayment of Debt
-89,291
-89,291
-50,492
-96,478
-77,984
Free Cash Flow
123,782
123,782
58,740
45,407
82,737
12/31/2021 - 7/7/1992
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GIKLY Grifols, S.A.
4.6500
0.00%
0R1F.IL Bristol-Myers Squibb Company
46.78
-2.96%
1BMY.MI Bristol-Myers Squibb Company
40.71
-2.96%
GIFOF Grifols, S.A.
8.25
0.00%
NOVA.SG Novo Nordisk A/S
59.50
+1.54%
REC.MI Recordati Industria Chimica e Farmaceutica S.p.A.
50.35
-2.71%
ORNBV.HE Orion Oyj
54.70
-1.26%
NOV.F Novo Nordisk A/S
57.85
-1.68%
SAN.PA Sanofi
88.84
-0.97%
NOV.DE Novo Nordisk A/S
57.91
-1.09%